SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-146629
Filing Date
2021-05-03
Accepted
2021-05-03 07:21:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d179453ddefa14a.htm DEFA14A 36636
  Complete submission text file 0001193125-21-146629.txt   37622
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36167 | Film No.: 21881312
SIC: 2834 Pharmaceutical Preparations